Discover What’s Next from SPI Pharma at CPHI Worldwide!
Where Formulation Performance Meets Patient Impact
SPI Pharma is excited to return to CPHI Worldwide in Frankfurt, where we’ll be unveiling the latest innovations that continue to shape the future of patient-friendly dosage forms and improving the quality of people's lives. Visit us at Booth #8.0P7 to explore two game-changing technologies redefining performance and versatility in formulation:
Compressol™ ProTab – our next-generation direct compression platform that’s setting a new standard for formulation flexibility and tablet performance. ProTab enables higher drug loads, supports challenging actives, and opens up new possibilities across a range of applications—from nutraceuticals to complex pharmaceutical formulations.
Valens™ AH 2.0 – a high-performance aluminium hydroxide adjuvant engineered for human vaccines. With 2% aluminium oxide, a positive surface charge for efficient antigen adsorption, and compatibility with other components to stimulate additional immune pathways, Valens™ AH 2.0 enhances antibody-mediated immune responses. It offers sterilized, scalable, cGMP- and Ph.Eur-compliant production you can trust, with flexible packaging and volumes for your vaccine programs.
And before CPHI begins, we’re hosting an exclusive pre-show webinar:
🎥 “The Next Generation of Direct Compression: Compressol™ ProTab”
📅 October 22, 2025
🔗 Register here
Join our experts to learn how ProTab is transforming formulation design and delivering real-world benefits across diverse dosage forms.
We can’t wait to connect with you in Frankfurt—stop by Booth #8.0P7 to meet our team, experience these technologies firsthand, and discover how SPI Pharma can help you bring better medicines to life.